Cargando…
MDMA (3,4-Methylenedioxymethamphetamine) Analogues as Tools to Characterize MDMA-Like Effects: An Approach to Understand Entactogen Pharmacology
Besides stimulants and hallucinogens, whose psychotropic effects are shared by many structurally related molecules exhibiting different efficacies and potencies in humans, the phenylisopropylamine MDMA (3,4-methylenedioxymethamphetamine, XTC, “Ecstasy”) is the prototypical representative of a separa...
Autores principales: | Sáez-Briones, P., Hernández, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763760/ https://www.ncbi.nlm.nih.gov/pubmed/24403876 http://dx.doi.org/10.2174/1570159X11311050007 |
Ejemplares similares
-
3,4-methylenedioxymethamphetamine (MDMA): current perspectives
por: Meyer, Jerrold S
Publicado: (2013) -
Effects of (±) 3,4-Methylenedioxymethamphetamine (MDMA) on Sleep and Circadian Rhythms
por: McCann, Una D., et al.
Publicado: (2007) -
A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy
por: Sessa, Ben, et al.
Publicado: (2019) -
A review on the mitochondrial toxicity of “ecstasy” (3,4-methylenedioxymethamphetamine, MDMA)
por: Capela, João Paulo, et al.
Publicado: (2022) -
Methylenedioxymethamphetamine (MDMA, ‘Ecstasy’): Neurodegeneration versus Neuromodulation
por: Puerta, Elena, et al.
Publicado: (2011)